Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lotemax vs Pred Forte for Prevention of Retinal Thickening After Cataract Surgery
NCT01193504Phase 4Unknown
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2010
- Primary completion
- Oct 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of loteprednol etabonate in cystoid macular edema (CME), sponsored by Janssen Pharmaceutical. Status: unknown.
02
Drugs
loteprednol etabonate
03
Conditions
cystoid macular edema (CME)
Beyond the preview
Go deeper on NCT01193504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01193504.